Anders Vik
Jakob Nordberg Nørgaard,
Kari Lenita Falck Moore,
Tobias Schmidt Slørdahl,
Anders Vik,
Tor Henrik Anderson Tvedt,
Fredrik Schjesvold
:
VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study
Alicia Villatoro,
Vincent Cuminetti,
Aurora Bernal Mera,
Carlos Torroja,
Itziar Cossío,
Alberto Benguría
et al.:
Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
Milton Boaheng Antewi,
Gianina Aurica Dumitriu,
Jaione Santamaria Simon,
Javier Sanchez Romano,
Ruomei Li,
Bård Smedsrød
et al.:
Liver sinusoidal endothelial cells show reduced scavenger function and downregulation of Fc gamma receptor IIb, yet maintain a preserved fenestration in the Glmp gt/gt mouse model of slowly progressing liver fibrosis
Fridtjof Balteskard Rinde,
Synne Grønvold Frønæs,
Waleed Khalid Ghanima,
Anders Vik,
John-Bjarne Hansen,
Sigrid Brækkan
:
D-dimer as a stand-alone test to rule out deep vein thrombosis
Ludvig Balteskard Rinde,
Birgit Småbrekke,
Erin Mathisen Hald,
Ellen Elisabeth Brodin,
Inger Njølstad,
Ellisiv B. Mathiesen
et al.:
Myocardial infarction and future risk of cancer in the general population?the Troms? Study
Anders Vik,
Ellen Elisabeth Brodin,
Ellisiv B. Mathiesen,
Jan Brox,
Lone Jørgensen,
Inger Njølstad
et al.:
Serum osteoprotegerin and renal function in the general population: The Troms? Study
Birgit Småbrekke,
Ludvig Balteskard Rinde,
Kristian Hindberg,
Erin Mathiesen Hald,
Anders Vik,
Tom Wilsgaard
et al.:
Atherosclerotic risk factors and risk of myocardial infarction and venous thromboembolism; Time-fixed versus time-varying analyses. The Troms? Study
Ynse Ieuwe Gerardus Vladimir Tichelaar,
Ellen Elisabeth Brodin,
Anders Vik,
Trond Isaksen,
Finn Egil Skjeldestad,
Satish Kumar
et al.:
A retrospective comparison of ultrasound-assisted catheter-directed thrombolysis and catheter-directed thrombolysis alone for treatment of proximal deep vein thrombosis
Ludvig Balteskard Rinde,
Caroline Lind,
Birgit Småbrekke,
Inger Njølstad,
Ellisiv B. Mathiesen,
Tom Wilsgaard
et al.:
Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study
Trond Isaksen,
Ynse Ieuwe Gerardus Vladimir Tichelaar,
Finn Egil Skjeldestad,
Ellen Elisabeth Brodin,
Anders Vik,
Kulbir Singh
et al.:
Inter-rater agreement between professional-rated and patient-rated scores of the Villalta scale for evaluation of the post-thrombotic syndrome
Thrombosis Research 2016 DOI
Jostein Lappegård,
Trygve Ellingsen,
Anders Vik,
Tove Skjelbakken,
Jan Brox,
Ellisiv B. Mathiesen
et al.:
Red cell distribution width and carotid atherosclerosis progression: The tromsø study
Anders Vik,
Ellen Elisabeth Brodin,
Ellisiv B. Mathiesen,
Jan Brox,
Lone Jørgensen,
Inger Njølstad
et al.:
Serum osteoprotegerin and future risk of cancer and cancer-related mortality in the general population: the Tromsø study
Emilio Besada,
Anders Vik,
Wenche Koldingsnes,
Johannes C Nossent
:
Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review
International journal of hematology 2013 DOI
Erin Mathiesen Hald,
Sigrid Kufaas Brækkan,
Anders Vik,
Ellen Elisabeth Brodin,
John-Bjarne Hansen
:
Postprandial lipemia is not increased in patients with previous unprovoked venous thromboembolism
Journal of Clinical Lipidology 2013 DOI
Ellen Elisabeth Brodin,
Gunhild Lerstad,
Guri Grimnes,
Sigrid Kufaas Brækkan,
Anders Vik,
Jan Brox
et al.:
Serum levels of vitamin D are not associated with future risk of venous thromboembolism The Tromso Study
Thrombosis and Haemostasis 2013 DOI
Lone Jørgensen,
John-Bjarne Hansen,
Luai A. Ahmed,
Åshild Bjørnerem,
Nina Emaus,
Ragnar Martin Joakimsen
et al.:
Osteoprotegerin is associated with hip fracture incidence: the Tromso Study
International Journal of Epidemiology 2012 SAMMENDRAG / DOI
Ellen Elisabeth Brodin,
Sigrid Kufaas Brækkan,
Anders Vik,
Jan Brox,
John-Bjarne Hansen
:
Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function - the Tromso study
Lone Jørgensen,
John-Bjarne Hansen,
Jan Brox,
Ellisiv B. Mathiesen,
Anders Vik,
Bjarne K. Jacobsen
:
Serum osteoprotegerin levels are related to height loss: The Tromsø Study
Anders Vik,
Ellisiv B. Mathiesen,
Jan Brox,
Tom Wilsgaard,
Inger Njølstad,
Lone Jørgensen
et al.:
Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromso Study
Journal of Thrombosis and Haemostasis 2011 DOI
Marie Søfteland Sandvei,
Ellisiv B. Mathiesen,
Lars Johan Vatten,
Tomm Brostrup Müller,
Haakon Lindekleiv,
Tor Ingebrigtsen
et al.:
Incidence and mortality of aneurysmal subarachnoid hemorrhage in two Norwegian cohorts, 1984-2007
Neurology 2011 DOI
Sigbjørn Berentsen,
Ulla Randen,
Anna Marita Vågan,
Henrik Hjort-Hansen,
Anders Vik,
Jakob Dalgaard
et al.:
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
Anders Vik,
Ellisiv B. Mathiesen,
jan Brox,
Tom Wilsgaard,
Inger Njølstad,
Lone Jørgensen
et al.:
Relation between serum osteoprotegerin and carotid intima media thickness in a general population - The Tromsø Study
Journal of Thrombosis and Haemostasis 2010 DOI
Lone Jørgensen,
Anders Vik,
Nina Emaus,
Jan Brox,
John-Bjarne Hansen,
Ellisiv B. Mathiesen
et al.:
Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappa B ligand: the Tromso Study
Osteoporosis International 2010 DOI
Anders Vik,
Ellisiv B. Mathiesen,
Stein Harald Johnsen,
Jan Brox,
Tom Wilsgaard,
Inger Njølstad
et al.:
Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population - the Troms circle divide study
Journal of Thrombosis and Haemostasis 2010 DOI
Anders Vik,
Guanglin Cui,
vidar Isaksen,
T Wik,
John-Bjarne Hansen
:
Erythropoietin Production by a Hepatic Adenoma in a Patient with Severe Erythrocytosis
Acta Haematologica 2009 DOI
Lone Jørgensen,
Anders Vik,
Nina Emaus,
jan Brox,
John-Bjarne Hansen,
Ellisiv B. Mathiesen
et al.:
Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappa B ligand: the Tromsø Study
Osteoporosis International 2009
Anders Vik,
Ellisiv B. Mathiesen,
Ann-Trude With Notø,
Baldur Sveinbjørnsson,
jan Brox,
John-Bjarne Hansen
:
Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans
Atherosclerosis 2007 DOI
Anders Vik,
Ellen Elisabeth Brodin,
Baldur Sveinbjørnsson,
John-Bjarne Hansen
:
Heparin induces mobilization of osteoprotegerin into the circulation
Thrombosis and Haemostasis 2007 DOI
Anders Vik,
Ellen Elisabeth Brodin,
Trond Børvik,
Baldur Sveinbjørnsson,
John-Bjarne Hansen
:
Serum osteoprotegerin in young survivors of myocardial infarction
Thrombosis and Haemostasis 2006
Anders Vik,
Ellisiv B. Mathiesen,
Ann-Trude With Notø,
Baldur Sveinbjørnsson,
Jan Brox,
John-Bjarne Hansen
:
Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans
Atherosclerosis 18. Apr 2006
Anders Vik,
reidar Berntsen,
vidar Isaksen,
Egil Haug,
John-Bjarne Hansen
:
Ein 53 år gammal mann med hovudverk og konsentrasjonsvanskar
Tidsskrift for Den norske legeforening 2005
Anders Vik,
Satish Kumar,
Kulbir Singh,
John-Bjarne Hansen
:
Lokal trombolytisk behandling og stent ved stenose i v. cava superior
Tidsskrift for Den norske legeforening 2003
Anders Vik,
Nina Helbekkmo,
Roy M. Bremnes
:
Låggradig non-Hodgkins lymfom i Nord-Noreg
Tidsskrift for Den norske legeforening 2002
Roy M. Bremnes,
Anders Vik,
Nina Helbekkmo
:
Low-grade non-Hodgkin's lymphoma in northern Norway: treatment, outcome, and prognostic factors
Anticancer Research 1998
Vincent Cuminetti,
Joanna Konieczny,
Aurora Bernal Mera,
Marc Ferre Oliver,
Manuel José Gomez,
Nuria Vilaplana-Lopera
et al.:
Succinate receptor 1 signaling regulates hematopoiesis via S100/a8 and S100/a9 in health and malignancy
2024
Alicia Elena Villatoro Gonzalez,
Vincent Cuminetti,
Aurora Bernal Mera,
Carlos Torroja,
Itziar Cossío,
Alberto Benguría
et al.:
Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation (Nature Communications, (2023), 14, 1, (12), 10.1038/s41467-022-35700-9)
Nature Communications 2023 DOI
Vincent Cuminetti,
Joanna Konieczny,
Aurora Bernal,
Alicia Villatoro,
Hagar Taman,
Marko Ristic
et al.:
Disruption of succinate receptor signaling promotes myeloproliferation and acute myeloid leukaemia
HemaSphere 2022 DOI
Hilde Jensvoll,
Marie Falkenberg Smeland,
Heidi Tiller,
Øystein Lunde Holla,
Trine Prescott,
Anders Vik
:
En gravid kvinne med pancytopeni
Tidsskrift for Den norske legeforening 2019 DOI
Anders Vik
:
Risiko for tilbakefall ved tidsbegrenset behandling av blodpropp
2015 FULLTEKST
Anders Vik
:
Ny kunnskap om molekylære mekanismer kan gi nye angrepspunkt for forebygging av blodpropp
2014 FULLTEKST
John-Bjarne Hansen,
Ellen Elisabeth Brodin,
Anders Vik,
Sigrid Kufaas Brækkan
:
Tromboseprofylakse ved sykehusinnleggelse for akutte indremedisinske tilstander – fra retningslinjer til klinisk praksis
2014 FULLTEKST
Anders Vik,
vidar Isaksen,
Jan Brox,
John-Bjarne Hansen
:
Ei kvinne i 50-åra med hovudverk, uklart syn og utslett
Tidsskrift for Den norske legeforening 2012 DOI
Anders Vik,
Ellen Elisabeth Brodin,
Sigrid Kufaas Brækkan,
John-Bjarne Hansen
:
Serum osteoprotegerin and future risk of venous thromboembolism. The Tromso study
Thrombosis Research 2012 DOI
The 50 latest publications is shown on this page. See all publications in Cristin here →